




Posting Date:2023-08-03
Views:
Summer flowers are in full bloom, and time flies. In the blink of an eye, the first half of 2023 has passed, and DASAN Pharmaceutical has embarked on a new journey for the second half of the year.
As the new journey begins, DASAN Pharmaceutical grandly held the "Shenyang DASAN Pharmaceutical 2023 Mid-Year Summary Meeting" on July 15. The meeting took place in Harbin, hosted by the Administration Department. Attendees included Vice Chairman Liu Zhenhao, General Manager Yan Dong, Dr. Wang Tao from Shanghai Gaozhun Pharmaceutical, Deputy General Manager Wang Xinyu, and all employees.

The meeting began with an opening address by Vice Chairman Liu Zhenhao. He stated that this summary meeting marked another gathering of the entire DASAN family. The company's continuous growth is attributed not only to the leadership's decisions but also to the hard work of every employee. In the future, he believes the company will flourish with everyone's efforts. He hopes to work together with all colleagues to lead DASAN Pharmaceutical to an even brighter future.
Deputy General Manager Wang Xinyu reviewed the team's work achievements, challenges, and lessons learned over the past period. Through this review, the past work was evaluated, helping everyone understand what succeeded, what needs improvement, and draw lessons from the experiences. He called on and encouraged all employees to actively respond to the company's directives, using them as a focus for the second half of the year, and to carry out all work solidly and effectively.
△ Summary by the Assistant General Manager
△ Summary by the Head of Production Department
△ Summary by the Head of Analytical Department
△ Summary by the Head of Regulatory Affairs Department
△ Summary by the Head of Quality Department
△ Summary by the Head of Finance Department
△ Summary by the Head of Formulation Department
△ Summary by the Head of API Department
The Assistant General Manager, heads of Production, Analytical, Regulatory Affairs, Quality, Finance, Formulation, and API departments each delivered their half-year summaries. Each department head summarized the work and achievements of the first half of the year, showcasing their efforts and breakthroughs in different areas, and outlined the key tasks for the second half. By reviewing the work of the past six months, identifying issues, sharing experiences, and learning from lessons, they aim to sprint toward the goals for the second half of the year in a stronger state.
Finally, General Manager Yan Dong reported on the company's operational performance for the first half of the year, emphasizing key data points that require attention in each sector. He fully affirmed the work of the middle management and expressed sincere gratitude for their hard work and cooperation over the past six months. At the same time, he pointed out areas needing improvement, urging everyone to confront issues honestly and consider ways to refine operational models, further increase revenue and reduce costs, and lower production expenses. He stressed the need to actively implement various measures to overcome challenges on the road ahead, emphasizing that each department must clarify responsibilities and hold individuals accountable. Leaders should lead by example, guide through words and actions, and manage with courage.
Halfway up the mountain, we do not stop; in the midstream of the river, we must row with determination. This meeting comprehensively reviewed and summarized the work of the first half of 2023, outlined the tasks and key measures for the next phase, bridging the past and the future with strengthened confidence. The battle for the second half has just begun. The entire company will surely forge ahead with unwavering resolve, pooling our strength, moving forward with courage and perseverance, and making every effort to accomplish all tasks and goals, driving the company toward high-quality development.